Philip Morris International Q2 2025 Performance Beats Expectations
On Tuesday, June 3, 2025, Philip Morris International (NYSE: PM) spoke at the Deutsche Bank Global Consumer Conference, highlighting its strategic focus on smoke-free products amid both opportunities and challenges. The company reported strong growth in i
On Tuesday, June 3, 2025, Philip Morris International (NYSE: PM) spoke at the Deutsche Bank Global Consumer Conference, showcasing its strategic focus on smoke-free products amidst opportunities and challenges. The company reported strong growth in its smoke-free product portfolio while maintaining resilience in its traditional tobacco business through strategic price adjustments and cost management.
<\/span><\/div>
<\/span><\/div>
<\/div>
Key Highlights:<\/span><\/div>
Philip Morris International aims for strong growth in revenue, operating profit, and adjusted earnings per share (excluding currency effects), primarily driven by its smoke-free product portfolio.<\/span><\/div>
The company plans to achieve two-thirds of its revenue from smoke-free products by 2030.<\/span><\/div>
Nicotine pouch product ZYN grew over 50% in the U.S. market in Q1 2025.<\/span><\/div>
Philip Morris International expects its traditional tobacco business to return to normal trends, anticipating a low single-digit decline.<\/span><\/div>
Financial Performance:<\/span><\/div>
Philip Morris International is expected to achieve strong financial performance in 2025, including:<\/span><\/div>
<\/div>
Organic revenue growth of 6% to 8%<\/span><\/div>
Organic operating profit growth of 10.5% to 12.5%<\/span><\/div>
Adjusted earnings per share (excluding currency effects) growth of 10.5% to 12.5%<\/span><\/div>
Positive currency effects leading to a 12% to 14% increase in adjusted earnings per share in USD<\/span><\/div>
<\/div>
<\/div>
The company's smoke-free product portfolio achieved significant milestones in Q1:<\/span><\/div>
<\/div>
Smoke-free product sales grew over 14%<\/span><\/div>
Smoke-free product revenue organic growth exceeded 20%<\/span><\/div>
Smoke-free product gross profit grew over 30%, with a gross margin of approximately 70%<\/span><\/div>
Operational Update:<\/span><\/div>
Philip Morris International continues to expand its smoke-free product offerings:<\/span><\/div>
<\/div>
IQOS: Despite regulatory challenges, it achieved nearly 10% growth in Japan and over 7% growth in Europe. Growth was also strong in Gulf countries, Indonesia, and Mexico.<\/span><\/div>
ZYN: Achieved over 50% growth in the U.S. and plans to further expand into Europe and other markets.<\/span><\/div>
Veev: Holds a leading position in five EU markets, focusing on profitable growth.<\/span><\/div>
The company's multi-category strategy has been implemented in 16 markets, aimed at enhancing consumer loyalty and achieving cross-brand growth.<\/span><\/div>
<\/div>
Future Outlook:<\/span><\/div>
Philip Morris International is determined to accelerate its smoke-free growth:<\/span><\/div>
<\/div>
Plans to expand IQOS in the U.S. and enter new markets such as Turkey, Brazil, and India.<\/span><\/div>
Expected to achieve a net debt to EBITDA ratio of 2x by the end of 2026.<\/span><\/div>
Once leverage targets are achieved, discussions on stock buyback plans will commence, and due to strong adjusted earnings per share performance, the company will focus on dividend growth.<\/span><\/div>
